Dr. Siddhartha Devarakonda
Claim this profileWashington University School of Medicine
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
14 reported clinical trials
30 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
EGFR positive
2Non-Small Cell Lung Cancer
Stage IV
Stage III
EGFR positive
Affiliated Hospitals
Clinical Trials Siddhartha Devarakonda is currently running
Neoantigen Vaccine + Durvalumab
for Small Cell Lung Cancer
This trial is testing a custom-made vaccine combined with an immune-boosting drug called durvalumab. It aims to help patients with advanced small cell lung cancer, a severe type of lung cancer that has spread widely. The vaccine targets unique markers on cancer cells, while durvalumab helps the immune system fight these cells more effectively.
Recruiting1 award Phase 212 criteria
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting1 award Phase 211 criteria
More about Siddhartha Devarakonda
Clinical Trial Related2 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Siddhartha Devarakonda has experience with
- Atezolizumab
- Docetaxel
- APL-101
- SM08502
- Pembrolizumab
- Durvalumab
Breakdown of trials Siddhartha Devarakonda has run
Lung Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Siddhartha Devarakonda specialize in?
Siddhartha Devarakonda focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Siddhartha Devarakonda currently recruiting for clinical trials?
Yes, Siddhartha Devarakonda is currently recruiting for 7 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Siddhartha Devarakonda has studied deeply?
Yes, Siddhartha Devarakonda has studied treatments such as Atezolizumab, Docetaxel, APL-101.
What is the best way to schedule an appointment with Siddhartha Devarakonda?
Apply for one of the trials that Siddhartha Devarakonda is conducting.
What is the office address of Siddhartha Devarakonda?
The office of Siddhartha Devarakonda is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.